These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4462865)

  • 1. In-vivo testing of polymers for thrombogenicity.
    Daniels AU; Mortensen JD
    Biomater Med Devices Artif Organs; 1974; 2(4):365-77. PubMed ID: 4462865
    [No Abstract]   [Full Text] [Related]  

  • 2. [Thromboresistance of polymeric materials in construction of an artificial heart and devices for assisted circulation].
    Chepurov AK; Kozlov VK
    Med Tekh; 1977; (2):22-6. PubMed ID: 881966
    [No Abstract]   [Full Text] [Related]  

  • 3. Microporous flow surface variation and short term thrombogenicity in dogs.
    White RA; Shors E; Miranda RM; Klein SR; Goldberg L; Bosco P; Nelson RJ
    Biomaterials; 1982 Jul; 3(3):145-9. PubMed ID: 7115857
    [No Abstract]   [Full Text] [Related]  

  • 4. Non-thrombogenicity of organic polymers by blending with alkylamine-heparin complexes.
    Kashiwagi T; Ito Y; Imanishi Y
    Biomaterials; 1993 Dec; 14(15):1145-53. PubMed ID: 8130319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet adhesion to heparin-bonded and heparin-free surfaces.
    Rembaum A; Yen SP; Ingram M; Newton JF; Hu CL
    Biomater Med Devices Artif Organs; 1973; 1(1):99-119. PubMed ID: 4766641
    [No Abstract]   [Full Text] [Related]  

  • 6. Study of surface charge of the intima and artificial materials in relation to thrombogenicity.
    Thubrikar M; Reich T; Cadoff I
    J Biomech; 1980; 13(8):663-6. PubMed ID: 6252208
    [No Abstract]   [Full Text] [Related]  

  • 7. [Theory of antithrombogenic surfaces. I].
    Hildebrandt J; Schaps P
    Z Exp Chir; 1973; 6(6):355-61. PubMed ID: 4601541
    [No Abstract]   [Full Text] [Related]  

  • 8. Three years' experience in vivo and in vitro with surfaces and devices treated by the heparin complex method.
    Leininger RI; Crowley JP; Falb RD; Grode GA
    Trans Am Soc Artif Intern Organs; 1972; 18(0):312-5. PubMed ID: 4610965
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of surface porosity on early thrombogenicity using vascular grafts with two surfaces in sequence.
    Goldberg L; Bosco P; Shors E; Klein S; Nelson R; White R
    Trans Am Soc Artif Intern Organs; 1981; 27():517-21. PubMed ID: 7331121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood compatibility of surfaces modified by plasma polymerization.
    Yeh YS; Iriyama Y; Matsuzawa Y; Hanson SR; Yasuda H
    J Biomed Mater Res; 1988 Sep; 22(9):795-818. PubMed ID: 3220845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of antithrombogenicity of a new heparinized hydrophilic polymer: chronic in vivo studies and clinical application.
    Idezuki Y; Watanabe H; Hagiwara M; Kanasugi K; Mori Y
    Trans Am Soc Artif Intern Organs; 1975; 21():436-49. PubMed ID: 1146018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomaterials in medical devices.
    Bruck SD
    Trans Am Soc Artif Intern Organs; 1972; 18(0):1-9. PubMed ID: 4610962
    [No Abstract]   [Full Text] [Related]  

  • 13. Factors influencing platelet consumption by polyacrylamide hydrogels.
    Hanson SR; Harker LA; Ratner BD; Hoffman AS
    Ann Biomed Eng; 1979; 7(3-4):357-67. PubMed ID: 121213
    [No Abstract]   [Full Text] [Related]  

  • 14. Reduced thrombogenicity of polymers having phospholipid polar groups.
    Ishihara K; Aragaki R; Ueda T; Watenabe A; Nakabayashi N
    J Biomed Mater Res; 1990 Aug; 24(8):1069-77. PubMed ID: 2394763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The current status of in vivo screening of synthetic implant materials for blood compatibility.
    Gott VL; Furuse A
    Med Instrum; 1973; 7(2):121-4. PubMed ID: 4718485
    [No Abstract]   [Full Text] [Related]  

  • 16. Thrombogenicity of a new injectable biocompatible elastomer for aneurysm exclusion, compared to expanded polytetrafluoroethylene in a human ex vivo model.
    van der Steenhoven TJ; Bosman WM; Tersteeg C; Jacobs MJ; Moll FL; de Groot PG; Heyligers JM
    Eur J Vasc Endovasc Surg; 2012 Jun; 43(6):675-80. PubMed ID: 22436262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance evaluation of hydroxylated and acylated silicone rubber coatings.
    Tsai CC; Dollar ML; Constantinescu A; Kulkarni PV; Eberhart RC
    ASAIO Trans; 1991; 37(3):M192-3. PubMed ID: 1751105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nature of thrombus in a hollow fiber oxygenator.
    Schneider MD
    Am J Vet Res; 1973 Feb; 34(2):151-68. PubMed ID: 4568247
    [No Abstract]   [Full Text] [Related]  

  • 19. Development of blood compatible silicone elastomers.
    Musolf MC; Hulce VD; Bennett DR; Ramos M
    Trans Am Soc Artif Intern Organs; 1969; 15():18-24. PubMed ID: 5791388
    [No Abstract]   [Full Text] [Related]  

  • 20. Thrombogenicity of heparin and non-heparin bound arterial prostheses: an in vitro evaluation.
    Mohamed MS; Mukherjee M; Kakkar VV
    J R Coll Surg Edinb; 1998 Jun; 43(3):155-7. PubMed ID: 9654873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.